2024-04-202025-04-302025-04-30false15663749Viola Health Limited2026-01-16falseiso4217:GBPxbrli:pure156637492024-04-19156637492025-04-30156637492024-04-202025-04-30156637492024-04-18156637492024-04-19156637492024-04-192024-04-1915663749bus:SmallEntities2024-04-202025-04-3015663749bus:AuditExempt-NoAccountantsReport2024-04-202025-04-3015663749bus:FullAccounts2024-04-202025-04-3015663749bus:PrivateLimitedCompanyLtd2024-04-202025-04-3015663749core:WithinOneYear2025-04-3015663749core:AfterOneYear2025-04-3015663749core:WithinOneYear2024-04-1915663749core:AfterOneYear2024-04-1915663749core:ShareCapital2025-04-3015663749core:SharePremium2025-04-3015663749core:RevaluationReserve2025-04-3015663749core:OtherReservesSubtotal2025-04-3015663749core:RetainedEarningsAccumulatedLosses2025-04-3015663749core:ShareCapital2024-04-1915663749core:SharePremium2024-04-1915663749core:RevaluationReserve2024-04-1915663749core:OtherReservesSubtotal2024-04-1915663749core:RetainedEarningsAccumulatedLosses2024-04-1915663749core:LandBuildings2025-04-3015663749core:PlantMachinery2025-04-3015663749core:Vehicles2025-04-3015663749core:FurnitureFittings2025-04-3015663749core:OfficeEquipment2025-04-3015663749core:NetGoodwill2025-04-3015663749core:IntangibleAssetsOtherThanGoodwill2025-04-3015663749core:ListedExchangeTraded2025-04-3015663749core:UnlistedNon-exchangeTraded2025-04-3015663749core:LandBuildings2024-04-1915663749core:PlantMachinery2024-04-1915663749core:Vehicles2024-04-1915663749core:FurnitureFittings2024-04-1915663749core:OfficeEquipment2024-04-1915663749core:NetGoodwill2024-04-1915663749core:IntangibleAssetsOtherThanGoodwill2024-04-1915663749core:ListedExchangeTraded2024-04-1915663749core:UnlistedNon-exchangeTraded2024-04-1915663749core:LandBuildings2024-04-202025-04-3015663749core:PlantMachinery2024-04-202025-04-3015663749core:Vehicles2024-04-202025-04-3015663749core:FurnitureFittings2024-04-202025-04-3015663749core:OfficeEquipment2024-04-202025-04-3015663749core:NetGoodwill2024-04-202025-04-3015663749core:IntangibleAssetsOtherThanGoodwill2024-04-202025-04-3015663749core:ListedExchangeTraded2024-04-202025-04-3015663749core:UnlistedNon-exchangeTraded2024-04-202025-04-3015663749core:MoreThanFiveYears2024-04-202025-04-3015663749core:Non-currentFinancialInstruments2025-04-3015663749core:Non-currentFinancialInstruments2024-04-1915663749dpl:CostSales2024-04-202025-04-3015663749dpl:DistributionCosts2024-04-202025-04-3015663749core:LandBuildings2024-04-202025-04-3015663749core:PlantMachinery2024-04-202025-04-3015663749core:Vehicles2024-04-202025-04-3015663749core:FurnitureFittings2024-04-202025-04-3015663749core:OfficeEquipment2024-04-202025-04-3015663749dpl:AdministrativeExpenses2024-04-202025-04-3015663749core:NetGoodwill2024-04-202025-04-3015663749core:IntangibleAssetsOtherThanGoodwill2024-04-202025-04-3015663749dpl:GroupUndertakings2024-04-202025-04-3015663749dpl:ParticipatingInterests2024-04-202025-04-3015663749dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-202025-04-3015663749core:ListedExchangeTraded2024-04-202025-04-3015663749dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-202025-04-3015663749core:UnlistedNon-exchangeTraded2024-04-202025-04-3015663749dpl:CostSales2024-04-192024-04-1915663749dpl:DistributionCosts2024-04-192024-04-1915663749core:LandBuildings2024-04-192024-04-1915663749core:PlantMachinery2024-04-192024-04-1915663749core:Vehicles2024-04-192024-04-1915663749core:FurnitureFittings2024-04-192024-04-1915663749core:OfficeEquipment2024-04-192024-04-1915663749dpl:AdministrativeExpenses2024-04-192024-04-1915663749core:NetGoodwill2024-04-192024-04-1915663749core:IntangibleAssetsOtherThanGoodwill2024-04-192024-04-1915663749dpl:GroupUndertakings2024-04-192024-04-1915663749dpl:ParticipatingInterests2024-04-192024-04-1915663749dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-192024-04-1915663749core:ListedExchangeTraded2024-04-192024-04-1915663749dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-192024-04-1915663749core:UnlistedNon-exchangeTraded2024-04-192024-04-1915663749core:NetGoodwill2025-04-3015663749core:IntangibleAssetsOtherThanGoodwill2025-04-3015663749core:LandBuildings2025-04-3015663749core:PlantMachinery2025-04-3015663749core:Vehicles2025-04-3015663749core:FurnitureFittings2025-04-3015663749core:OfficeEquipment2025-04-3015663749core:AfterOneYear2025-04-3015663749core:WithinOneYear2025-04-3015663749core:ListedExchangeTraded2025-04-3015663749core:UnlistedNon-exchangeTraded2025-04-3015663749core:ShareCapital2025-04-3015663749core:SharePremium2025-04-3015663749core:RevaluationReserve2025-04-3015663749core:OtherReservesSubtotal2025-04-3015663749core:RetainedEarningsAccumulatedLosses2025-04-3015663749core:NetGoodwill2024-04-1915663749core:IntangibleAssetsOtherThanGoodwill2024-04-1915663749core:LandBuildings2024-04-1915663749core:PlantMachinery2024-04-1915663749core:Vehicles2024-04-1915663749core:FurnitureFittings2024-04-1915663749core:OfficeEquipment2024-04-1915663749core:AfterOneYear2024-04-1915663749core:WithinOneYear2024-04-1915663749core:ListedExchangeTraded2024-04-1915663749core:UnlistedNon-exchangeTraded2024-04-1915663749core:ShareCapital2024-04-1915663749core:SharePremium2024-04-1915663749core:RevaluationReserve2024-04-1915663749core:OtherReservesSubtotal2024-04-1915663749core:RetainedEarningsAccumulatedLosses2024-04-1915663749core:NetGoodwill2024-04-1815663749core:IntangibleAssetsOtherThanGoodwill2024-04-1815663749core:LandBuildings2024-04-1815663749core:PlantMachinery2024-04-1815663749core:Vehicles2024-04-1815663749core:FurnitureFittings2024-04-1815663749core:OfficeEquipment2024-04-1815663749core:AfterOneYear2024-04-1815663749core:WithinOneYear2024-04-1815663749core:ListedExchangeTraded2024-04-1815663749core:UnlistedNon-exchangeTraded2024-04-1815663749core:ShareCapital2024-04-1815663749core:SharePremium2024-04-1815663749core:RevaluationReserve2024-04-1815663749core:OtherReservesSubtotal2024-04-1815663749core:RetainedEarningsAccumulatedLosses2024-04-1815663749core:AfterOneYear2024-04-202025-04-3015663749core:WithinOneYear2024-04-202025-04-3015663749core:Non-currentFinancialInstrumentscore:CostValuation2024-04-202025-04-3015663749core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-202025-04-3015663749core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-202025-04-3015663749core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-202025-04-3015663749core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-202025-04-3015663749core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-202025-04-3015663749core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-202025-04-3015663749core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-202025-04-3015663749core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-202025-04-3015663749core:Non-currentFinancialInstrumentscore:CostValuation2025-04-3015663749core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-3015663749core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-3015663749core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-3015663749core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-3015663749core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-3015663749core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-3015663749core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-3015663749core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-3015663749core:Non-currentFinancialInstrumentscore:CostValuation2024-04-1915663749core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-1915663749core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-1915663749core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-1915663749core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-1915663749core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-1915663749core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-1915663749core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-1915663749core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-1915663749bus:Director12024-04-202025-04-30

Viola Health Limited

Registered Number
15663749
(England and Wales)

Unaudited Financial Statements for the Period ended
30 April 2025

Viola Health Limited
Company Information
for the period from 20 April 2024 to 30 April 2025

Director

Shilpeshkumar Kanubhai Patel

Company Secretary

Shilpeshkumar Kanubhai Patel

Registered Address

231 Kenton Road
Harrow
HA3 0HD

Registered Number

15663749 (England and Wales)
Viola Health Limited
Statement of Financial Position
30 April 2025

Notes

2025

£

£

Fixed assets
Tangible assets3357,000
Investments4984,900
1,341,900
Current assets
Debtors5120,426
Cash at bank and on hand8,770
129,196
Creditors amounts falling due within one year6(495,729)
Net current assets (liabilities)(366,533)
Total assets less current liabilities975,367
Creditors amounts falling due after one year7(953,685)
Net assets21,682
Capital and reserves
Called up share capital300
Profit and loss account21,382
Shareholders' funds21,682
The financial statements were approved and authorised for issue by the Director on 16 January 2026, and are signed on its behalf by:
Shilpeshkumar Kanubhai Patel
Director
Registered Company No. 15663749
Viola Health Limited
Notes to the Financial Statements
for the period ended 30 April 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the money received or expected. As the company is a holding company, turnover includes income from its investments and management services provided to subsidiary companies.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Tangible fixed assets and depreciation
Fixed assets are initially recorded at cost. The company’s fixed assets consist of an investment in a subsidiary and property used for administrative purposes. These assets are stated in the balance sheet using the historic cost model.
Investments
The company holds an investment in the shares of its subsidiary, Shivson Ltd (purchase of pharmacy business). This investment was originally recorded at the cost of purchase, including all related legal and transaction fees. As of 20 April 2024, the value of this investment is shown as £984,900. No reduction in value (impairment) has been recorded during this period.
2.Average number of employees

2025
Average number of employees during the year0
3.Tangible fixed assets

Land & buildings

Total

££
Cost or valuation
Additions357,000357,000
At 30 April 25357,000357,000
Net book value
At 30 April 25357,000357,000
At 19 April 24--
4.Fixed asset investments

Investments in groups1

Total

££
Cost or valuation
Additions984,900984,900
At 30 April 25984,900984,900
Net book value
At 30 April 25984,900984,900

Notes

1Investments in group undertakings and participating interests
5.Debtors: amounts due within one year

2025

£
Other debtors120,426
Total120,426
6.Creditors: amounts due within one year

2025

£
Trade creditors / trade payables36,600
Taxation and social security5,015
Other creditors454,114
Total495,729
Other creditors: As of the balance sheet date, the total amount of £454,114 under other creditors includes the following related party balances: Intercompany Balance: An amount of £422,936 is owed to Cross Retail Limited. This balance is interest-free and has no fixed date for repayment. Director's Current Account: An amount of £31,178 is owed to the director. This is an interest-free loan from the director to the company and is repayable on demand and subject to availability of funds.
7.Creditors: amounts due after one year

2025

£
Bank borrowings and overdrafts953,685
Total953,685